Pyxis Oncology Announces Up To $114 Million Private Placement Financing To Advance Micvo Through Key Clinical Milestones

Pyxis Oncology Inc NASDAQ:PYXS:

• PYXIS ONCOLOGY ANNOUNCES UP TO $114 MILLION PRIVATE PLACEMENT FINANCING TO ADVANCE MICVO THROUGH KEY CLINICAL MILESTONES

• PYXIS ONCOLOGY - UPFRONT PROCEEDS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2027

• PYXIS ONCOLOGY - SELLS 19.6 MILLION SHARES AT $2.55 EACH WITH WARRANTS AT $3.29 EXERCISE PRICE

• PYXIS ONCOLOGY: FINANCING LED BY BVF PARTNERS L.P. WITH PARTICIPATION FROM GORDONMD GLOBAL INVESTMENTS, RTW INVESTMENTS, COASTLANDS CAPITAL

• PYXIS ONCOLOGY - EXPECTS UPDATED PHASE 1 MONOTHERAPY DATA IN FALL 2026 AND PHASE 1/2 DATA IN Q4 2026